Sanjib Bhakta

Has grant

Professor of Molecular Microbiology and Biochemistry

Birkbeck University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Microbiology Microbiology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Sanjib Bhakta is a faculty member in the Department of Molecular Microbiology and Biochemistry at Birkbeck, University of London, UK. His research focuses on the development of novel antimycobacterial agents, including the design of pyrazoline-based compounds and carprofen analogues aimed at combating Mycobacterium tuberculosis. He also investigates the immunobiology of tubercle bacilli and explores innovative approaches to enhancing the efficacy of existing antibiotics through rational drug design and combination therapies.

Recent Grants

Grant: Close

ATP-dependent Mur ligases in Mycobacterium tuberculosis: search for potential therapeutic targets against Tuberculosis.

Open Date: 2009-10-01

Close Date: 2013-09-01

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Rachael Dickman

Lecturer in Drug Discovery

University College London

UNITED KINGDOM

View details

Paul Stapleton

University College London

UNITED KINGDOM

View details

Harprit Singh

Associate Professor/Reader

De Montfort University

UNITED KINGDOM

View details

Ester Boix

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Dimitrios Evangelopoulos

Lecturer in Microbiology

University College London Eastman Dental Institute

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sanjib Bhakta

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives

Development of Carprofen analogues with activity against Mycobacterium tuberculosis

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays

Antimicrobial Peptides Designed against the Ω-Loop of Class A β-Lactamases to Potentiate the Efficacy of β-Lactam Antibiotics

C2‐linked alkynyl poly‐ethylene glycol(PEG) adenosine conjugates as water‐soluble adenosine receptor agonists

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics

C-1 Substituted isoquinolines potentiate the antimycobacterial activity of rifampicin and ethambutol

The Phytochemistry and Pharmacology of <i>Tulbaghia</i>, <i>Allium</i>, <i>Crinum</i> and <i>Cyrtanthus</i>: ‘Talented’ Taxa from the Amaryllidaceae

Role of AmpC-Inducing Genes in Modulating Other Serine Beta-Lactamases in Escherichia coli

A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy

Antibacterial and Antifungal Activities of Andrographolide in Combination with Antimicrobial Drugs

Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections

Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages

Investigating Ghanaian Allium Species for Anti-Infective and Resistance-Reversal Natural Product Leads to Mitigate Multidrug-Resistance in Tuberculosis

Correction: Lu et al. Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages. Antibiotics 2021, 10, 97

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review

Bioactive Compounds from the Bornean Endemic Plant Goniothalamus longistipetes

Collaborators (5)

Rachael Dickman

Paul Stapleton

Harprit Singh

Ester Boix

Dimitrios Evangelopoulos

Make your next move.